(IN BRIEF) The Fresenius healthcare group is constructing a new facility, KabiLab D20, at Daimlerstrasse 20 on its Bad Homburg campus, set to cover 5,000 m². This modern laboratory and office building will feature state-of-the-art laboratories, 90 shared workstations, meeting … Read the full press release
Posted in Business, Construction, Environment, Financial, Germany, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged 000 m², 5, Bad Homburg, clinical nutrition leader, CO₂ reduction, Daimlerstrasse 20, Diabetes, employee relocation, Fresenius healthcare group, Fresenius Kabi Business Unit Nutrition, Fresubin enteral nutrition, heat pump, innovative products, KabiLab D20, laboratory and office building, metabolic disorders, Oberursel, patient-specific parenteral nutrition, Photovoltaic Systems, Rainwater harvesting, sustainability
London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that the US Court of Appeals for the Federal Circuit (CAFC) lifted a temporary injunction against the US launch of Hanmi’s 505(b)2 NDA esomeprazole strontium product. AstraZeneca’s CAFC appeal of claim construction … Read the full press release
Posted in Business, Government, Healthcare, Law, Pharma & Biotech, United Kingdom
Tagged 192, 5, 504, 714, 877, Amneal Pharmaceuticals, Anthony Brown, AstraZeneca, CAFC, Colleen Proctor, Court of Appeals for the Federal Circuit, Ed Seage, Esra Erkal-Paler, Hanmi, Hanmi Pharmaceutical, Hanmi's 505(b)2 NDA esomeprazole strontium, Jacob Lund, Jens Lindberg, Karl Hård, Michele Meixell, New Jersey, Nexium, patent-infringement damages, Temporary injunction, US launch, Vanessa Rhodes
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?